Skip to content
healthcare.dev

Rivaroxaban

NDC 60505-6256, Rivaroxaban, tablet, film coated, from Apotex Corp..

Product NDC
60505-6256
Status
Listed
Labeler
Apotex Corp.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217810
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6256 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVAROXABAN2.5 mg/1

Pharmacologic classes

Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]

Package NDCNDC-11Package
60505-6256-560505625605500 TABLET, FILM COATED in 1 BOTTLE (60505-6256-5)
60505-6256-66050562560660 TABLET, FILM COATED in 1 BOTTLE (60505-6256-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e98f6d83-5172-97a1-ee41-5d7d1d8ba2fd
  • NADAC price for package 60505625606

    GET /v1/drugs/nadac/60505625606

Use it

Look up 60505-6256 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6256 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-6256. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.